Science Today

Prof.Dr Mohsen Ibrahim article III

THE BETA BLOCKADE DILEMMA The role of beta-adrenergic blocking drugs in the initial management of hypertensive patients has been recently challenged after the publication of the results of two large drug trials (LIFE and ASCOT) and meta-analysis (Lindholm et al.) to the extent that the recent...

Prof.Dr.Mohsen Ibrahim article IV

WHAT IS NEW IN CLINICAL HYPERTENSION? The aim of this message is to provide a summary of some of important recent advances in the field of clinical hypertension. Development in basic and experimental hypertension will not be discussed. Modern research in clinical hypertension covered areas of...

Prof.Dr.Mohsen Ibrahim article V

Several aspects of diet have been implicated in the pathogenesis of hypertension. These include: excess salt, low K intake, excess weight, high alcohol consumption and unhealthy diet. In non-hypertensive individuals, dietary changes can delay or even prevent hypertension. The original DASH diet...

Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension.

This was a multicenter, open-label, observational, noninterventional, postmarketing surveillance study conducted in 298 centers in China, Malaysia, Pakistan, Bangladesh, Egypt, and Russia. We evaluated changes in heart rate, systolic and diastolic office blood pressure (BP), as well as BP control...

Angina pectoris

commonly known as angina, is chest pain due to ischemia (a lack of blood, thus a lack of oxygen supply and waste removal) of the heart muscle, generally due to obstruction or spasm of the coronary arteries . Coronary artery disease, the main cause of angina, is due to atherosclerosis of the...